Cargando…

GVBD rate is an independent predictor for pregnancy in ICSI patients with surplus immature oocytes

INTRODUCTION: It was reported that there were still up to 30% immature retrieved oocyte at germinal vesicle (GV) or metaphase I (MI) stage. Whether the spontaneous maturity competency of immature oocytes associated to the clinical outcome of in vitro fertilization (IVF) cycles remains unclear and un...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Meng, Yang, Qiyu, Liu, Jing, Hu, Juan, Li, Dan, Ren, Xinling, Xi, Qingsong, Zhu, Lixia, Jin, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868552/
https://www.ncbi.nlm.nih.gov/pubmed/36699025
http://dx.doi.org/10.3389/fendo.2022.1022044
_version_ 1784876563509018624
author Wang, Meng
Yang, Qiyu
Liu, Jing
Hu, Juan
Li, Dan
Ren, Xinling
Xi, Qingsong
Zhu, Lixia
Jin, Lei
author_facet Wang, Meng
Yang, Qiyu
Liu, Jing
Hu, Juan
Li, Dan
Ren, Xinling
Xi, Qingsong
Zhu, Lixia
Jin, Lei
author_sort Wang, Meng
collection PubMed
description INTRODUCTION: It was reported that there were still up to 30% immature retrieved oocyte at germinal vesicle (GV) or metaphase I (MI) stage. Whether the spontaneous maturity competency of immature oocytes associated to the clinical outcome of in vitro fertilization (IVF) cycles remains unclear and unexplored. This study aimed to investigate how the oocyte developmental parameters in in vitro maturation (IVM) affect clinical outcomes of intracytoplasmic sperm injection (ICSI) cycles. METHODS: This retrospective cohort study included couples undergoing ICSI in a university-affiliated hospital. Surplus immature oocytes during ICSI were collected and cultured in vitro. The numbers of germinal vesicle (GV) oocytes undergoing GV breakdown (GVBD) and polar body 1 extrusion within 24 h culture were recorded. The main outcome measurements were demographic baselines and oocyte developmental parameters in IVM associated with pregnancy outcomes. RESULTS: A total of 191 couples were included with an overall GVBD rate of 63.7% (327/513) and oocyte maturation rate of 46.8% (240/513). 53.4% (102/191) of them had embryos transferred freshly, which originated from metaphase II oocytes that matured spontaneously in vivo, and 60.8% (62/102) got pregnant. Among factors with a P-value < 0.2 in univariate logistic regression analyses of pregnancy correlation, GVBD rate (OR 3.220, 95% CI 1.060-9.782, P=0.039) and progesterone level on human chorionic gonadotropin (HCG) day (OR 0.231, 95% CI 0.056-0.949, P=0.042) remained significant in the multivariate model. The area under the curve (AUC) of the predictive nomogram was 0.729 (95% CI 0.632-0.826) with an acceptable calibration. Moreover, decision curve analyses illustrated the superior overall net benefit of models that included the GVBD rate in clinical decisions within a wide range of threshold probabilities. CONCLUSION: In conclusion, GVBD rate and progesterone level on HCG day may be associated with pregnancy outcomes in infertile couples during the regular ICSI procedure. An elevated GVBD rate within 24 h may greatly increase the likelihood of pregnancy in infertile couples during ICSI. This preliminary study may optimize clinical pregnancy prediction, which provides support in decision-making in clinical practice.
format Online
Article
Text
id pubmed-9868552
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98685522023-01-24 GVBD rate is an independent predictor for pregnancy in ICSI patients with surplus immature oocytes Wang, Meng Yang, Qiyu Liu, Jing Hu, Juan Li, Dan Ren, Xinling Xi, Qingsong Zhu, Lixia Jin, Lei Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: It was reported that there were still up to 30% immature retrieved oocyte at germinal vesicle (GV) or metaphase I (MI) stage. Whether the spontaneous maturity competency of immature oocytes associated to the clinical outcome of in vitro fertilization (IVF) cycles remains unclear and unexplored. This study aimed to investigate how the oocyte developmental parameters in in vitro maturation (IVM) affect clinical outcomes of intracytoplasmic sperm injection (ICSI) cycles. METHODS: This retrospective cohort study included couples undergoing ICSI in a university-affiliated hospital. Surplus immature oocytes during ICSI were collected and cultured in vitro. The numbers of germinal vesicle (GV) oocytes undergoing GV breakdown (GVBD) and polar body 1 extrusion within 24 h culture were recorded. The main outcome measurements were demographic baselines and oocyte developmental parameters in IVM associated with pregnancy outcomes. RESULTS: A total of 191 couples were included with an overall GVBD rate of 63.7% (327/513) and oocyte maturation rate of 46.8% (240/513). 53.4% (102/191) of them had embryos transferred freshly, which originated from metaphase II oocytes that matured spontaneously in vivo, and 60.8% (62/102) got pregnant. Among factors with a P-value < 0.2 in univariate logistic regression analyses of pregnancy correlation, GVBD rate (OR 3.220, 95% CI 1.060-9.782, P=0.039) and progesterone level on human chorionic gonadotropin (HCG) day (OR 0.231, 95% CI 0.056-0.949, P=0.042) remained significant in the multivariate model. The area under the curve (AUC) of the predictive nomogram was 0.729 (95% CI 0.632-0.826) with an acceptable calibration. Moreover, decision curve analyses illustrated the superior overall net benefit of models that included the GVBD rate in clinical decisions within a wide range of threshold probabilities. CONCLUSION: In conclusion, GVBD rate and progesterone level on HCG day may be associated with pregnancy outcomes in infertile couples during the regular ICSI procedure. An elevated GVBD rate within 24 h may greatly increase the likelihood of pregnancy in infertile couples during ICSI. This preliminary study may optimize clinical pregnancy prediction, which provides support in decision-making in clinical practice. Frontiers Media S.A. 2023-01-09 /pmc/articles/PMC9868552/ /pubmed/36699025 http://dx.doi.org/10.3389/fendo.2022.1022044 Text en Copyright © 2023 Wang, Yang, Liu, Hu, Li, Ren, Xi, Zhu and Jin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Wang, Meng
Yang, Qiyu
Liu, Jing
Hu, Juan
Li, Dan
Ren, Xinling
Xi, Qingsong
Zhu, Lixia
Jin, Lei
GVBD rate is an independent predictor for pregnancy in ICSI patients with surplus immature oocytes
title GVBD rate is an independent predictor for pregnancy in ICSI patients with surplus immature oocytes
title_full GVBD rate is an independent predictor for pregnancy in ICSI patients with surplus immature oocytes
title_fullStr GVBD rate is an independent predictor for pregnancy in ICSI patients with surplus immature oocytes
title_full_unstemmed GVBD rate is an independent predictor for pregnancy in ICSI patients with surplus immature oocytes
title_short GVBD rate is an independent predictor for pregnancy in ICSI patients with surplus immature oocytes
title_sort gvbd rate is an independent predictor for pregnancy in icsi patients with surplus immature oocytes
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868552/
https://www.ncbi.nlm.nih.gov/pubmed/36699025
http://dx.doi.org/10.3389/fendo.2022.1022044
work_keys_str_mv AT wangmeng gvbdrateisanindependentpredictorforpregnancyinicsipatientswithsurplusimmatureoocytes
AT yangqiyu gvbdrateisanindependentpredictorforpregnancyinicsipatientswithsurplusimmatureoocytes
AT liujing gvbdrateisanindependentpredictorforpregnancyinicsipatientswithsurplusimmatureoocytes
AT hujuan gvbdrateisanindependentpredictorforpregnancyinicsipatientswithsurplusimmatureoocytes
AT lidan gvbdrateisanindependentpredictorforpregnancyinicsipatientswithsurplusimmatureoocytes
AT renxinling gvbdrateisanindependentpredictorforpregnancyinicsipatientswithsurplusimmatureoocytes
AT xiqingsong gvbdrateisanindependentpredictorforpregnancyinicsipatientswithsurplusimmatureoocytes
AT zhulixia gvbdrateisanindependentpredictorforpregnancyinicsipatientswithsurplusimmatureoocytes
AT jinlei gvbdrateisanindependentpredictorforpregnancyinicsipatientswithsurplusimmatureoocytes